Overview

Complete treatment in a single dose

1 applicatorful administered once intravaginally as a single dose at any time of day.

Learn more about dosing

Thermosetting formulation for gradual release of clindamycin¹

XACIATO vaginal gel increases viscosity at body temperature and gradually releases clindamycin over time.^a

Click video below to learn more about XACIATO.

^aBased on an in vitro study using clindamycin HCl.¹

Learn more about the formulation

Clear efficacy at Day 21–30 and Day 7–14

Superior Clinical Cure^b vs placebo at Day 21–30, with significant results as early as Day 7–14.

Treatment difference:

• Day 21–30: 34.9%; 95% CI: 19.0, 50.8; P<0.001
• Day 7–14: 52.5%; 95% CI: 38.0, 67.0; P<0.001

Robust efficacy in both new and recurrent BV

Significantly higher Clinical Cure at Day 21–30 vs placebo in both subsets of patients with ≤3 episodes or >3 episodes (recurrent) of BV in the past 12 months.

Treatment difference²:

• ≤3 episodes of BV in the past 12 months: 32.2%; 95% CI: 13.9, 50.4; P=0.001 (XACIATO: N=101, placebo: N=46)
• Recurrent BV: 46.9%; 95% CI: 10.1, 83.7; P=0.01 (XACIATO: N=20, placebo: N=13)

^bClinical Cure = resolution of the abnormal vaginal discharge associated with BV, a negative 10% KOH whiff test, and clue cells <20% of the total epithelial cells in the saline wet mount.

Learn more about clinical efficacy

Eligible patients pay as little as $25*

Learn more about patient savings

*Eligibility Criteria

By participating in this savings program, participants understand and agree that de-identified, non-personally identifiable information obtained from the pharmacy will be shared with the manufacturer. Participants also affirm that they will not submit, and have not had submitted on their behalf, a claim for reimbursement or coverage for items purchased with this program under Medicaid, Medicare, TRICARE, or any other federal or state government health care program, or where prohibited by state law.

By participating in this savings program, you acknowledge and agree to the following terms and conditions:

• Commercially insured patients may pay as little as $25. Offer applies to out-of-pocket expenses (co-pay) greater than $25. Eligibility parameters and benefit limitations apply.
• Offer applies only to patients receiving XACIATO^® (clindamycin phosphate) vaginal gel 2% and associated refills.
• This offer is not valid for prescriptions paid in part or in full by any federally or state-funded program, including but not limited to Medicaid, Medicare, Department of Veterans Affairs, Department of Defense, or TRICARE, and where prohibited by law.
• This savings program cannot be combined with any other coupon, cash discount card, certificate, voucher, or similar offer.
• Offer good only in the United States at participating retail pharmacies and cannot be redeemed at government-subsidized clinics. Void where taxed, restricted, or prohibited by law.
• Offer not extended to clubs, groups, or organizations.
• Participation in this program must comply with all applicable laws and contractual or other obligations as a pharmacy provider.
• This is not an insurance program.
• Any step-edits or prior authorizations required by the insurance plan still apply.
• ORGANON RESERVES THE RIGHT TO MODIFY OR CANCEL THIS PROGRAM AT ANY TIME WITHOUT NOTICE.
• eVoucherRx™ is not extended on prescriptions for any of the following patients:
  • who are cash-paying customers.
  • using institution-based pharmacies to fill their prescriptions, or who are recipients of federal or state government health care.
  • who are filling their prescriptions at non-participating pharmacies.

eVoucherRx™ is a trademark of RelayHealth.

BV = bacterial vaginosis; HCl = hydrochloride; KOH = potassium hydroxide.